Intellia Therapeutics Inc (NASDAQ:NTLA)

48.27
Delayed Data
As of 3:59pm ET
 -1.41 / -2.84%
Today’s Change
37.08
Today|||52-Week Range
130.33
-59.18%
Year-to-Date
No recent news for Intellia Therapeutics Inc.

Today’s Trading

Previous close49.68
Today’s open49.85
Day’s range47.80 - 50.64
Volume25,777
Average volume (3 months)1,040,352
Market cap$3.9B
Data as of 3:59pm ET, 11/28/2022

Growth & Valuation

Earnings growth (last year)-57.61%
Earnings growth (this year)-62.23%
Earnings growth (next 5 years)+13.22%
Revenue growth (last year)-43.01%
P/E ratioNM
Price/Sales253.61
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
DNLIDenali Therapeutics ...-1.12-3.74%
CRSPCRISPR Therapeutics ...-1.63-2.96%
----
ARWRArrowhead Pharmaceut...-0.89-3.02%
Data as of 4:00pm ET, 11/28/2022

Financials

Next reporting dateMarch 15, 2023
EPS forecast (this quarter)-$1.37
Annual revenue (last year)$33.1M
Annual profit (last year)-$267.9M
Net profit margin-810.49%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts